Steven-Huy Han is a Gastroenterology physician affiliated with University of California, Los Angeles. OpenAlex indexes 20 publications with 1,629 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Ucla Medical Plz Ste 700
Los Angeles, CA 900246997
Telephone
310-794-7783Provider last certified this registry record 6 Jan 2025.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202525 payments$43,497openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202515 payments$35,520openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
53.7%Nucleoside and nucleotide reverse transcriptase inhibitors53.7%Vemlidy85%Tenofovir Disoproxil Fumarate15%Part D<11 patientsMetabolism & gastrointestinal
26%Rifamycin Antibacterial12.1%Xifaxan100%Part D<11 patientsBile Acid9.6%Ursodiol100%Part D<11 patients+ 1 more class in this area
Cardiovascular
20.3%Loop diuretic10%Furosemide100%Part D≥11 patientsAldosterone antagonist (MRA)5.7%Spironolactone100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2008–2025 per NIH RePORTER. The latest:
- The UCLA Center in Early Detection of Liver Cancer
University of California Los Angeles
FY2025$866,250U01CA230705 - The UCLA Center in Early Detection of Liver Cancer
University of California Los Angeles
FY2024$822,938U01CA230705 - MethylScan for Early Detection of Liver and Lung Cancer
Earlydiagnostics, Inc.
FY2023$997,285R44CA246941
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus in Two Southern California Counties
Journal of Viral Hepatitis
2026 - Mental Health Diseases Are Associated With Active Hepatitis C and Partly Drive Hepatocellular Carcinoma Trends in Veterans
Clinical Gastroenterology and Hepatology
2025 - Real-World Study on Sofosbuvir-based Therapies in Asian Americans With Chronic Hepatitis C
Journal of Clinical Gastroenterology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”